Algert Global LLC
- SEC CIK
- 0001275218
- Latest filing
- Aug 13, 2026
ENTA holding history
Enanta Pharmaceuticals Inc in every 13F filed by Algert Global LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ENTA overviewAll 13F holders of ENTAFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −11,106−100.0% | Sold out | Holders |
| Q3 2025 | 11,106 | $132.9K | <0.1% | +11,106 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −29,364−100.0% | Sold out | Holders |
| Q3 2023 | 29,364 | $328.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 29,364 | $628.4K | <0.1% | +12,160+70.7% | Added | Holders |
| Q1 2023 | 17,204 | $695.7K | <0.1% | +724+4.4% | Added | Holders |
| Q4 2022 | 16,480 | $766.6K | <0.1% | −7,030−29.9% | Reduced | Holders |
| Q3 2022 | 23,510 | $1.22M | 0.1% | −5,510−19.0% | Reduced | Holders |
| Q2 2022 | 29,020 | $1.37M | 0.1% | +10,560+57.2% | Added | Holders |
| Q1 2022 | 18,460 | $1.31M | 0.1% | +18,460 | New | Holders |